Xilio Therapeutics Inc (XLO)
1.14
+0.05
(+4.59%)
USD |
NASDAQ |
May 15, 14:38
Xilio Therapeutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
Gilead Sciences Inc | 43.18% |
FibroGen Inc | 99.37% |
Avalo Therapeutics Inc | 99.98% |
IGM Biosciences Inc | -- |
AEON Biopharma Inc | -- |